(Q38009653)

26 August 2017

title

What's the role of topiramate in the management of patients with hyperkinetic movement disorders? (English)

1 reference

26 August 2017

3

Chiara Giofrè

0 references

Giovambattista De Sarro

4

object named as

Giovambattista De Sarro

0 references

author name string

Antonio Siniscalchi

1

1 reference

26 August 2017

Luca Gallelli

2

1 reference

26 August 2017

Chiara Giofrè

3

1 reference

26 August 2017

Giovambattista De Sarro

4

1 reference

26 August 2017

publication date

1 January 2012

1 reference

26 August 2017

published in

Pharmacological Reports

1 reference

26 August 2017

volume

64

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

24-30

1 reference

Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Restless legs syndrome induced by topiramate: two more cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Is the anticonvulsant topiramate beneficial in essential tremor?

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Chorea and related disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Caffeine and the anticonvulsant potency of antiepileptic drugs: experimental and clinical data.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

A double-blind placebo-controlled trial of topiramate treatment for essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Functional anatomy of movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Topiramate in the prevention of migraine: a review of its efficacy, tolerability, and acceptability

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Hemichorea-hemiballismus may respond to topiramate

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

GABAergic circuits in the basal ganglia and movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Vascular hemichorea/hemiballism and topiramate

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Topiramate therapy for paroxysmal kinesigenic choreoathetosis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Treatment of hyperkinetic movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Dystonia and chorea in acquired systemic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

How are we doing with the treatment of essential tremor (ET)?: Persistence of patients with ET on medication: data from 528 patients in three settings

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Pharmacotherapy of essential tremor : an overview of existing and upcoming agents

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

[Pathophysiology of restless legs syndrome]

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Psychopharmacology of topiramate: from epilepsy to bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Topiramate in essential tremor: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Topiramate: a new antiepileptic drug

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Synaptic control of motoneuronal excitability.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Action tremor with alternating activity in antagonist muscles

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Restless legs syndrome: an update on treatment options

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Topiramate: preclinical evaluation of structurally novel anticonvulsant.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Safety of topiramate: adverse events and relationships to dosing

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Efficacy and tolerability of topiramate in vascular generalized chorea

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Combined topiramate and declorazepam therapy in a patient affected by essential tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Drugs treatment of pain in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Review of topiramate for the treatment of epilepsy in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

10.1016/S1734-1140(12)70727-2

Identifiers

DOI

1 reference

26 August 2017

1 reference